Information  X 
Enter a valid email address

Tiziana Life SciencesPLC Ord3P (TILS)

Date Time Source Announcement
01 Nov 2019 7:00 am
RNS
Issue of CLN
30 Oct 2019 10:31 am
RNS
Change to ADS ratio
30 Sep 2019 7:00 am
RNS
Half-year Report
16 Sep 2019 7:00 am
RNS
Further re: Update on IND Application
10 Sep 2019 7:00 am
RNS
Phase 1 Clinical Data
04 Sep 2019 7:00 am
RNS
Phase 2a Clinical Data
21 Aug 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
06 Aug 2019 7:00 am
RNS
Proposed U.S. Public Offering
22 Jul 2019 7:00 am
RNS
Phase 2a Clinical Data
01 Jul 2019 7:00 am
RNS
Teplizumab Article
28 Jun 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  10:54 am
RNS
Change of Adviser
25 Jun 2019 7:00 am
RNS
Director/PDMR Shareholding
24 Jun 2019 7:00 am
RNS
Article on Clinical Activity of OKT3
11 Jun 2019 7:00 am
RNS
Director/PDMR Shareholding
07 Jun 2019 9:44 am
RNS
Director/PDMR Shareholding
03 Jun 2019 7:00 am
RNS
PDMR Dealings
31 May 2019 11:05 am
RNS
Result of AGM
28 May 2019 7:00 am
RNS
9th Annual LD Micro Invitational
07 May 2019 7:00 am
RNS
Notice of AGM
02 May 2019 7:00 am
RNS
Director/PDMR Shareholding
01 May 2019 7:00 am
RNS
Update on IND Application
25 Apr 2019 5:00 pm
RNS
Director/PDMR Shareholding
  11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
24 Apr 2019 12:55 pm
RNS
Reissue: Interim Clinical Data
  7:00 am
RNS
Interim Clinical Data
15 Apr 2019 5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
  5:45 pm
RNS
Holding(s) in Company
04 Apr 2019 7:00 am
RNS
Final Results
20 Mar 2019 7:00 am
RNS
IND Application Submitted for NASH Oral Treatment
07 Feb 2019 7:00 am
RNS
Directorate Change
11 Dec 2018 7:00 am
RNS
Exercise of Warrants & Issue of Equity
03 Dec 2018 7:00 am
RNS
Milciclib HCC Phase IIa Trial Enrollment Completed
28 Nov 2018 7:00 am
RNS
Foralumab: Phase 1 Trial with Nasal Administration
27 Nov 2018 7:00 am
RNS
Holding(s) in Company
26 Nov 2018 7:00 am
RNS
Statement re: ADSs
23 Nov 2018 5:00 pm
RNS
Closing of Offering and Total Voting Rights
20 Nov 2018 7:30 am
RNS
Discounted exercise prices of outstanding warrants
  7:00 am
RNS
Offer Pricing, Nasdaq Listing & Loan Conversion
26 Oct 2018 5:30 pm
RNS
Issue of Equity
18 Oct 2018 7:15 am
RNS
Amended Registration Statement filed with the SEC
16 Oct 2018 7:00 am
RNS
Milciclib synergistic activity presented at AASLD
25 Sep 2018 7:00 am
RNS
Tiziana announces Offering & Application to Nasdaq
24 Sep 2018 7:03 am
RNS
Interim Results for Six Months Ended 30 June 2018
  7:00 am
RNS
U.S. FDA Approval IND Nasal Foralumab Phase 1
13 Sep 2018 1:05 pm
RNS
PDMR Dealing
12 Sep 2018 7:00 am
RNS
PDMR dealings
11 Sep 2018 7:00 am
RNS
PDMR Dealing
24 Aug 2018 7:00 am
RNS
PDMR Dealing
21 Aug 2018 7:00 am
RNS
PDMR dealings
20 Aug 2018 7:00 am
RNS
PDMR Dealing
17 Aug 2018 7:00 am
RNS
PDMR Dealing
16 Aug 2018 9:00 am
RNS
Filing of Investigational New Drug application
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t